Search research articles
Contact Us
Filters
Showing results (91-100 of 98) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 98 results.
Toxicology and Applied Pharmacology
|
April 27, 2024
Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives
Osama A Mohammed, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 10, 2022
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
Mohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 21, 2026
Retraction notice to "Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling" [Biomedicine & Pharmacotherapy 158 (2023) 114196]
Sameh Saber, Eslam E Abd El-Fattah, Amir Mohamed Abdelhamid, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 7, 2024
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A Mohammed, Mahmoud E Youssef, Ahmed S Doghish, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 14, 2023
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E Abd El-Fattah, Amir Mohamed Abdelhamid, et al.
Frontiers in Pharmacology
|
June 27, 2022
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
Amir Mohamed Abdelhamid, Mahmoud E Youssef, Simona Cavalu, et al.
Plos One
|
October 31, 2024
Unlocking vinpocetine's oncostatic potential in early-stage hepatocellular carcinoma: A new approach to oncogenic modulation by a nootropic drug
Osama A Mohammed, Mahmoud E Youssef, Rabab S Hamad, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 98) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 98 results.
Toxicology and Applied Pharmacology
|
April 27, 2024
Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives
Osama A Mohammed, Sameh Saber, Mustafa Ahmed Abdel-Reheim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
August 10, 2022
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
Simona Cavalu, Hossam Sharaf, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
Mohamed Nasr, Simona Cavalu, Sameh Saber, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 21, 2026
Retraction notice to "Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling" [Biomedicine & Pharmacotherapy 158 (2023) 114196]
Sameh Saber, Eslam E Abd El-Fattah, Amir Mohamed Abdelhamid, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 7, 2024
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis
Osama A Mohammed, Mahmoud E Youssef, Ahmed S Doghish, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
March 14, 2023
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
Sameh Saber, Eslam E Abd El-Fattah, Amir Mohamed Abdelhamid, et al.
Frontiers in Pharmacology
|
June 27, 2022
Carbocisteine as a Modulator of Nrf2/HO-1 and NFκB Interplay in Rats: New Inspiration for the Revival of an Old Drug for Treating Ulcerative Colitis
Amir Mohamed Abdelhamid, Mahmoud E Youssef, Simona Cavalu, et al.
Plos One
|
October 31, 2024
Unlocking vinpocetine's oncostatic potential in early-stage hepatocellular carcinoma: A new approach to oncogenic modulation by a nootropic drug
Osama A Mohammed, Mahmoud E Youssef, Rabab S Hamad, et al.
Page
of 10